Industry News
Ambri seals deal with Sydney biomed network
Biosensor company Ambri is to set up a clinical trial and research link with Sydney's Royal North Shore Hospital as part of a wider deal with the BioMed North group of medical facilities. [ + ]
US paper man boosts Genesis NZ
New Zealand biotech Genesis Research and Development has successfully lured an ex-US heavyweight to head up its increased push into the plant biotech arena. [ + ]
Premier Bionics claims sleep trial success
Premier Bionics has announced a successful clinical trial for its AirwayClear device for non-invasive detection and diagnosis of obstructive sleep apnoea (OSA), providing support for commercial discussions and laying the groundwork for a larger trial. [ + ]
Prima: we're OK until 2004
Despite dwindling cash reserves, Prima BioMed has reassured the Australian Stock Exchange that it has enough resources to support it at least through the first quarter of 2004. [ + ]
Cytopia to use Start grant in pulmonary disorder work
Melbourne biomedical company Cytopia has won a $1.7 million AusIndustry Start grant to develop treatments for chronic obstructive pulmonary disorder (COPD), a currently untreatable condition that affects more than 600 million people worldwide. [ + ]
Biostart invests in Qld start-up Farmacule
Queensland's government has bought a slice of farming's value-added future with a $125,000 investment in Farmacule Bioindustries.. [ + ]
Metabolic to spend $2.1m grant on clinical trials
Metabolic Pharmaceuticals (ASX:MBP) has been granted an R&D Start grant of up to AUD$2.1 million to conduct its Phase IIb clinical trial for its obesity drug AOD9604. [ + ]
Sirtex records massive result, but Gray warns of slowdown
Sirtex Medical has reported an increase in revenues of 1368 per cent, recording more than AUD$10 million in revenues for the 12 months ending June 30, and an after-tax profit of $3.15 million. [ + ]
Trounson hasn't resigned: NSCC
Prof Alan Trounson has not resigned from the National Stem Cell Centre, contrary to a report in today's The Australian newspaper. [ + ]
WEHI's Vaux wins Victoria Prize
Walter and Eliza Hall Institute cancer researcher Dr David Vaux has been awarded the 2003 Victoria Prize for his pioneering work on the how, when and why of cell death. [ + ]
Iatia's cash flow prompts ASX query
Microscopy company Iatia has received a 'please explain' from the Australian Stock Exchange after its fourth quarter results showed the company had a net negative operating cash flow for the quarter of AUD$671,000 and $296,000 cash remaining. [ + ]
Prana surges on new Alzheimer's lead
Shares in Melbourne-based Prana Biotechnology Ltd (ASX:PBT, NASDAQ:PRAN) surged 18 per cent today on news that the company had selected a new, more potent lead compound as a potential preventative therapy and treatment for Alzheimer's disease and related neurodegenerative disorders. [ + ]
CSIRO adds commerce to board
CSIRO has beefed up its board with two new non-executive members, one of whom -- Brian Keane -- is a former CEO of insurance giant AAMI. The other is Prof Alan Robson, vice-chancellor elect of the University of Western Australia. [ + ]
NZ firm Virionyx hits rich research vein
New Zealand biotech Virionyx has hit a rich vein with a development deal for a frontline therapy suitable for a range of high-level infections such as AIDS, SARS, West Nile virus and dengue fever -- plus bioterrorism threats. [ + ]
Cochlear inventor: study confirmed my research
Cochlear implant inventor Prof Graeme Clark said today that a US study released this week on the risk of meningitis in children receiving cochlear implants confirmed his findings from many years of research. [ + ]
